APO Research

APO RESEARCH · REPORT

PROTAC Technology

Selected research

Market Outlook & Growth Opportunities

Global PROTAC Technology Market Outlook and Growth Opportunities 2026

Market perspective

The global PROTAC Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for PROTAC Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for PROTAC Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PROTAC Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the PROTAC Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the PROTAC Technology market include Arvinas, Captor therapeutics, Pfizer, Amgen, Oerth Bio, Bayer, Kymera, Nurix and C4 Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global PROTAC Technology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of PROTAC Technology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PROTAC Technology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global PROTAC Technology market.

PROTAC Technology Segment by Company

Arvinas

Captor therapeutics

Pfizer

Amgen

Oerth Bio

Bayer

Kymera

Nurix

C4 Therapeutics, Inc.

Astellas Pharma Inc.

AbbVie

Kaituo Pharmaceutical

Betta Pharmaceuticals

Hengrui Medicine

BeiGene

Haichuang Pharmaceutical

East China Pharmaceutical Group

PROTAC Technology Segment by Type

Based on CRBN

Based on VHL

PROTAC Technology Segment by Application

Breast Cancer

Prostate Cancer

Colorectal Cancer

Pancreatic Cancer

Lymphoma

Androgenic Alopecia

Others

PROTAC Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global PROTAC Technology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the PROTAC Technology key companies, revenue, market share, and recent developments.

3. To split the PROTAC Technology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions PROTAC Technology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify PROTAC Technology significant trends, drivers, influence factors in global and regions.

6. To analyze PROTAC Technology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PROTAC Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PROTAC Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PROTAC Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global PROTAC Technology industry.

Chapter 3: Detailed analysis of PROTAC Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of PROTAC Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of PROTAC Technology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. PROTAC Technology Industry Trends Table 2. PROTAC Technology Industry Drivers Table 3. PROTAC Technology Industry Opportunities and Challenges Table 4. PROTAC Technology Industry Restraints Table 5. Global PROTAC Technology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global PROTAC Technology Revenue Share by Company (2021-2026) Table 7. Global PROTAC Technology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global PROTAC Technology Key Company Manufacturing Base & Headquarters Table 9. Global PROTAC Technology Company, Product Type & Application Table 10. Global PROTAC Technology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global PROTAC Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Based on CRBN Table 15. Significant Companies of Based on VHL Table 16. Global PROTAC Technology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global PROTAC Technology Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global PROTAC Technology Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global PROTAC Technology Sales Value Share by Type (2021-2026) Table 20. Global PROTAC Technology Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Breast Cancer Table 22. Significant Companies of Prostate Cancer Table 23. Significant Companies of Colorectal Cancer Table 24. Significant Companies of Pancreatic Cancer Table 25. Significant Companies of Lymphoma Table 26. Significant Companies of Androgenic Alopecia Table 27. Significant Companies of Others Table 28. Global PROTAC Technology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global PROTAC Technology Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global PROTAC Technology Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global PROTAC Technology Sales Value Share by Application (2021-2026) Table 32. Global PROTAC Technology Sales Value Share by Application (2027-2032) Table 33. Global PROTAC Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global PROTAC Technology Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global PROTAC Technology Sales Value Share by Region (2021-2026) Table 36. Global PROTAC Technology Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global PROTAC Technology Sales Value Share by Region (2027-2032) Table 38. Global PROTAC Technology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global PROTAC Technology Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global PROTAC Technology Sales Value Market Share by Country (2021-2026) Table 41. Global PROTAC Technology Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global PROTAC Technology Sales Value Market Share by Country (2027-2032) Table 43. Arvinas Company Information Table 44. Arvinas Business Overview Table 45. Arvinas PROTAC Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Arvinas PROTAC Technology Product Portfolio Table 47. Arvinas Recent Development Table 48. Captor therapeutics Company Information Table 49. Captor therapeutics Business Overview Table 50. Captor therapeutics PROTAC Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Captor therapeutics PROTAC Technology Product Portfolio Table 52. Captor therapeutics Recent Development Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer PROTAC Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Pfizer PROTAC Technology Product Portfolio Table 57. Pfizer Recent Development Table 58. Amgen Company Information Table 59. Amgen Business Overview Table 60. Amgen PROTAC Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Amgen PROTAC Technology Product Portfolio Table 62. Amgen Recent Development Table 63. Oerth Bio Company Information Table 64. Oerth Bio Business Overview Table 65. Oerth Bio PROTAC Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Oerth Bio PROTAC Technology Product Portfolio Table 67. Oerth Bio Recent Development Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer PROTAC Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bayer PROTAC Technology Product Portfolio Table 72. Bayer Recent Development Table 73. Kymera Company Information Table 74. Kymera Business Overview Table 75. Kymera PROTAC Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Kymera PROTAC Technology Product Portfolio Table 77. Kymera Recent Development Table 78. Nurix Company Information Table 79. Nurix Business Overview Table 80. Nurix PROTAC Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Nurix PROTAC Technology Product Portfolio Table 82. Nurix Recent Development Table 83. C4 Therapeutics, Inc. Company Information Table 84. C4 Therapeutics, Inc. Business Overview Table 85. C4 Therapeutics, Inc. PROTAC Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. C4 Therapeutics, Inc. PROTAC Technology Product Portfolio Table 87. C4 Therapeutics, Inc. Recent Development Table 88. Astellas Pharma Inc. Company Information Table 89. Astellas Pharma Inc. Business Overview Table 90. Astellas Pharma Inc. PROTAC Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Astellas Pharma Inc. PROTAC Technology Product Portfolio Table 92. Astellas Pharma Inc. Recent Development Table 93. AbbVie Company Information Table 94. AbbVie Business Overview Table 95. AbbVie PROTAC Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. AbbVie PROTAC Technology Product Portfolio Table 97. AbbVie Recent Development Table 98. Kaituo Pharmaceutical Company Information Table 99. Kaituo Pharmaceutical Business Overview Table 100. Kaituo Pharmaceutical PROTAC Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Kaituo Pharmaceutical PROTAC Technology Product Portfolio Table 102. Kaituo Pharmaceutical Recent Development Table 103. Betta Pharmaceuticals Company Information Table 104. Betta Pharmaceuticals Business Overview Table 105. Betta Pharmaceuticals PROTAC Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Betta Pharmaceuticals PROTAC Technology Product Portfolio Table 107. Betta Pharmaceuticals Recent Development Table 108. Hengrui Medicine Company Information Table 109. Hengrui Medicine Business Overview Table 110. Hengrui Medicine PROTAC Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Hengrui Medicine PROTAC Technology Product Portfolio Table 112. Hengrui Medicine Recent Development Table 113. BeiGene Company Information Table 114. BeiGene Business Overview Table 115. BeiGene PROTAC Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. BeiGene PROTAC Technology Product Portfolio Table 117. BeiGene Recent Development Table 118. Haichuang Pharmaceutical Company Information Table 119. Haichuang Pharmaceutical Business Overview Table 120. Haichuang Pharmaceutical PROTAC Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Haichuang Pharmaceutical PROTAC Technology Product Portfolio Table 122. Haichuang Pharmaceutical Recent Development Table 123. East China Pharmaceutical Group Company Information Table 124. East China Pharmaceutical Group Business Overview Table 125. East China Pharmaceutical Group PROTAC Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. East China Pharmaceutical Group PROTAC Technology Product Portfolio Table 127. East China Pharmaceutical Group Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. PROTAC Technology Product Image Figure 2. Global PROTAC Technology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PROTAC Technology Market Size (2021-2032) & (US$ Million) Figure 4. Global PROTAC Technology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Based on CRBN Image Figure 8. Based on VHL Image Figure 9. Global PROTAC Technology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global PROTAC Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global PROTAC Technology Sales Value Share by Type (2021-2032) Figure 12. Breast Cancer Image Figure 13. Prostate Cancer Image Figure 14. Colorectal Cancer Image Figure 15. Pancreatic Cancer Image Figure 16. Lymphoma Image Figure 17. Androgenic Alopecia Image Figure 18. Others Image Figure 19. Global PROTAC Technology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global PROTAC Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global PROTAC Technology Sales Value Share by Application (2021-2032) Figure 22. Global PROTAC Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global PROTAC Technology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America PROTAC Technology Sales Value (2021-2032) & (US$ Million) Figure 25. North America PROTAC Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe PROTAC Technology Sales Value (2021-2032) & (US$ Million) Figure 27. Europe PROTAC Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific PROTAC Technology Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific PROTAC Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America PROTAC Technology Sales Value (2021-2032) & (US$ Million) Figure 31. South America PROTAC Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa PROTAC Technology Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa PROTAC Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt PROTAC Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt PROTAC Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt PROTAC Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Based on CRBN
  • Based on VHL
Applications
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • Lymphoma
  • Androgenic Alopecia
  • Others
Companies covered
  • Arvinas
  • Captor therapeutics
  • Pfizer
  • Amgen
  • Oerth Bio
  • Bayer
  • Kymera
  • Nurix
  • C4 Therapeutics, Inc.
  • Astellas Pharma Inc.
  • AbbVie
  • Kaituo Pharmaceutical
  • Betta Pharmaceuticals
  • Hengrui Medicine
  • BeiGene
  • Haichuang Pharmaceutical
  • East China Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global PROTAC Technology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global PROTAC Technology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 PROTAC Technology Market Dynamics
  1. 2.1 PROTAC Technology Industry Trends
  2. 2.2 PROTAC Technology Industry Drivers
  3. 2.3 PROTAC Technology Industry Opportunities and Challenges
  4. 2.4 PROTAC Technology Industry Restraints
3 PROTAC Technology Market by Company
  1. 3.1 Global PROTAC Technology Company Revenue Ranking in 2025
  2. 3.2 Global PROTAC Technology Revenue by Company (2021-2026)
  3. 3.3 Global PROTAC Technology Company Ranking (2024-2026)
  4. 3.4 Global PROTAC Technology Company Manufacturing Base and Headquarters
  5. 3.5 Global PROTAC Technology Company Product Type and Application
  6. 3.6 Global PROTAC Technology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global PROTAC Technology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 PROTAC Technology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 PROTAC Technology Market by Type
  1. 4.1 PROTAC Technology Type Introduction
  2. 4.1.1 Based on CRBN
  3. 4.1.2 Based on VHL
  4. 4.2 Global PROTAC Technology Sales Value by Type
  5. 4.2.1 Global PROTAC Technology Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global PROTAC Technology Sales Value by Type (2021-2032)
  7. 4.2.3 Global PROTAC Technology Sales Value Share by Type (2021-2032)
5 PROTAC Technology Market by Application
  1. 5.1 PROTAC Technology Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Colorectal Cancer
  5. 5.1.4 Pancreatic Cancer
  6. 5.1.5 Lymphoma
  7. 5.1.6 Androgenic Alopecia
  8. 5.1.7 Others
  9. 5.2 Global PROTAC Technology Sales Value by Application
  10. 5.2.1 Global PROTAC Technology Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global PROTAC Technology Sales Value by Application (2021-2032)
  12. 5.2.3 Global PROTAC Technology Sales Value Share by Application (2021-2032)
6 PROTAC Technology Regional Value Analysis
  1. 6.1 Global PROTAC Technology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PROTAC Technology Sales Value by Region (2021-2032)
  3. 6.2.1 Global PROTAC Technology Sales Value by Region: 2021-2026
  4. 6.2.2 Global PROTAC Technology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America PROTAC Technology Sales Value (2021-2032)
  7. 6.3.2 North America PROTAC Technology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe PROTAC Technology Sales Value (2021-2032)
  10. 6.4.2 Europe PROTAC Technology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific PROTAC Technology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific PROTAC Technology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America PROTAC Technology Sales Value (2021-2032)
  16. 6.6.2 South America PROTAC Technology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa PROTAC Technology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa PROTAC Technology Sales Value Share by Country, 2025 VS 2032
7 PROTAC Technology Country-level Value Analysis
  1. 7.1 Global PROTAC Technology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global PROTAC Technology Sales Value by Country (2021-2032)
  3. 7.2.1 Global PROTAC Technology Sales Value by Country (2021-2026)
  4. 7.2.2 Global PROTAC Technology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA PROTAC Technology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada PROTAC Technology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico PROTAC Technology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany PROTAC Technology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France PROTAC Technology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. PROTAC Technology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy PROTAC Technology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain PROTAC Technology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia PROTAC Technology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands PROTAC Technology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries PROTAC Technology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China PROTAC Technology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan PROTAC Technology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea PROTAC Technology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India PROTAC Technology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia PROTAC Technology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia PROTAC Technology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil PROTAC Technology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina PROTAC Technology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile PROTAC Technology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia PROTAC Technology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru PROTAC Technology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia PROTAC Technology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel PROTAC Technology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE PROTAC Technology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey PROTAC Technology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran PROTAC Technology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran PROTAC Technology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt PROTAC Technology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt PROTAC Technology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt PROTAC Technology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Arvinas
  2. 8.1.1 Arvinas Company Information
  3. 8.1.2 Arvinas Business Overview
  4. 8.1.3 Arvinas PROTAC Technology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Arvinas PROTAC Technology Product Portfolio
  6. 8.1.5 Arvinas Recent Developments
  7. 8.2 Captor therapeutics
  8. 8.2.1 Captor therapeutics Company Information
  9. 8.2.2 Captor therapeutics Business Overview
  10. 8.2.3 Captor therapeutics PROTAC Technology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Captor therapeutics PROTAC Technology Product Portfolio
  12. 8.2.5 Captor therapeutics Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer PROTAC Technology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer PROTAC Technology Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Amgen
  20. 8.4.1 Amgen Company Information
  21. 8.4.2 Amgen Business Overview
  22. 8.4.3 Amgen PROTAC Technology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amgen PROTAC Technology Product Portfolio
  24. 8.4.5 Amgen Recent Developments
  25. 8.5 Oerth Bio
  26. 8.5.1 Oerth Bio Company Information
  27. 8.5.2 Oerth Bio Business Overview
  28. 8.5.3 Oerth Bio PROTAC Technology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Oerth Bio PROTAC Technology Product Portfolio
  30. 8.5.5 Oerth Bio Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer PROTAC Technology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer PROTAC Technology Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 Kymera
  38. 8.7.1 Kymera Company Information
  39. 8.7.2 Kymera Business Overview
  40. 8.7.3 Kymera PROTAC Technology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kymera PROTAC Technology Product Portfolio
  42. 8.7.5 Kymera Recent Developments
  43. 8.8 Nurix
  44. 8.8.1 Nurix Company Information
  45. 8.8.2 Nurix Business Overview
  46. 8.8.3 Nurix PROTAC Technology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nurix PROTAC Technology Product Portfolio
  48. 8.8.5 Nurix Recent Developments
  49. 8.9 C4 Therapeutics, Inc.
  50. 8.9.1 C4 Therapeutics, Inc. Company Information
  51. 8.9.2 C4 Therapeutics, Inc. Business Overview
  52. 8.9.3 C4 Therapeutics, Inc. PROTAC Technology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 C4 Therapeutics, Inc. PROTAC Technology Product Portfolio
  54. 8.9.5 C4 Therapeutics, Inc. Recent Developments
  55. 8.10 Astellas Pharma Inc.
  56. 8.10.1 Astellas Pharma Inc. Company Information
  57. 8.10.2 Astellas Pharma Inc. Business Overview
  58. 8.10.3 Astellas Pharma Inc. PROTAC Technology Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Astellas Pharma Inc. PROTAC Technology Product Portfolio
  60. 8.10.5 Astellas Pharma Inc. Recent Developments
  61. 8.11 AbbVie
  62. 8.11.1 AbbVie Company Information
  63. 8.11.2 AbbVie Business Overview
  64. 8.11.3 AbbVie PROTAC Technology Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AbbVie PROTAC Technology Product Portfolio
  66. 8.11.5 AbbVie Recent Developments
  67. 8.12 Kaituo Pharmaceutical
  68. 8.12.1 Kaituo Pharmaceutical Company Information
  69. 8.12.2 Kaituo Pharmaceutical Business Overview
  70. 8.12.3 Kaituo Pharmaceutical PROTAC Technology Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Kaituo Pharmaceutical PROTAC Technology Product Portfolio
  72. 8.12.5 Kaituo Pharmaceutical Recent Developments
  73. 8.13 Betta Pharmaceuticals
  74. 8.13.1 Betta Pharmaceuticals Company Information
  75. 8.13.2 Betta Pharmaceuticals Business Overview
  76. 8.13.3 Betta Pharmaceuticals PROTAC Technology Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Betta Pharmaceuticals PROTAC Technology Product Portfolio
  78. 8.13.5 Betta Pharmaceuticals Recent Developments
  79. 8.14 Hengrui Medicine
  80. 8.14.1 Hengrui Medicine Company Information
  81. 8.14.2 Hengrui Medicine Business Overview
  82. 8.14.3 Hengrui Medicine PROTAC Technology Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hengrui Medicine PROTAC Technology Product Portfolio
  84. 8.14.5 Hengrui Medicine Recent Developments
  85. 8.15 BeiGene
  86. 8.15.1 BeiGene Company Information
  87. 8.15.2 BeiGene Business Overview
  88. 8.15.3 BeiGene PROTAC Technology Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BeiGene PROTAC Technology Product Portfolio
  90. 8.15.5 BeiGene Recent Developments
  91. 8.16 Haichuang Pharmaceutical
  92. 8.16.1 Haichuang Pharmaceutical Company Information
  93. 8.16.2 Haichuang Pharmaceutical Business Overview
  94. 8.16.3 Haichuang Pharmaceutical PROTAC Technology Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Haichuang Pharmaceutical PROTAC Technology Product Portfolio
  96. 8.16.5 Haichuang Pharmaceutical Recent Developments
  97. 8.17 East China Pharmaceutical Group
  98. 8.17.1 East China Pharmaceutical Group Company Information
  99. 8.17.2 East China Pharmaceutical Group Business Overview
  100. 8.17.3 East China Pharmaceutical Group PROTAC Technology Revenue and Gross Margin (2021-2026)
  101. 8.17.4 East China Pharmaceutical Group PROTAC Technology Product Portfolio
  102. 8.17.5 East China Pharmaceutical Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research